top of page
Search

The Institute Naming Illusion

  • 4 days ago
  • 4 min read

How health systems name service lines, and what the institute label must require


Paul Schrimpf, Christine Arbesman


Click here for a PDF | Click here for the audio podcast version


Specialty service lines for health systems often adopt the descriptor “institute” in healthcare, but it is inconsistently defined. The term can mean anything from a branded service line to a research-driven specialty platform. Some systems use it to signal destination care or academic strength, while others apply it mainly as a marketing label with little operational change.


That inconsistency makes the concept useful for branding but weak as a standard organizational model. In many cases, institutes overlap with service lines and departments, and the same functions appear under different labels across systems. One organization may give an institute its own leadership, budget, and metrics; another may use the name without changing governance at all.


Practice Area Over the Address


These structures are also largely location-agnostic. Whether called a service line, center, or institute, they are usually aligned to a practice area or patient need rather than a single physical site or mailing address. In that sense, they are meant to unify care across locations, not define care by where it happens.


That is also where naming discipline tends to break down. Institutes get named for the building or the campus that houses them, which quietly converts an organizing principle into an address and forces a rename every time the footprint changes. Patients and referring physicians search by condition, not by street, so the descriptor should travel with the practice area wherever the care is delivered. Descriptors are wayfinding, not positioning. Treated as infrastructure rather than decoration, a name follows the practice area instead of the real estate.


Fragmenting Brand Building Efforts


Worse yet, some specialty institutes carry donor names, which can further separate them from the health system’s core brand identity. In those cases, a system’s best care experiences may be associated with a different name altogether, rather than reinforcing equity in the parent brand.


The result is a fragmented brand architecture in which the most advanced or prestigious care does not always strengthen the health system that actually delivers it. A system may be pouring capital into its cancer institute while the parent brand receives no recognition for it. Over enough cycles, that is capital spent building an identity the system does not own.


What Earns the Label, and What Doesn’t


To be fair, no single descriptor of a service line will have a measurable impact on its performance. The brand on top will carry the most equity, the name of the specialty acts as navigation, and whether it is a center or an institute is a minor factor by comparison. Even so, a great deal of executive time is spent debating whether something is a standard service line or an elite institute. The longer that debate runs, the more it costs. The framework below is one way to end it.


What doesn’t get the institute descriptor matters just as much as what does. Without both sides managed, the contrast disappears and the label stops meaning anything. If the cafeteria renames itself the food service institute, the orthopedics institute looks less impressive. And while there are no “descriptor police,” here are some common criteria by which institutes claim to separate from standard service lines. Read the columns as additive rather than either/or: an institute is expected to do everything a standard service line does, and then everything below it.



The Have-Nots Need Managing Too


Every standard also creates a group of leaders who did not clear it, and their reaction is predictable. The cardiology team hears that orthopedics got an institute and reads it as a verdict on their value rather than a description of research infrastructure and referral pull. That is worth taking seriously, because unmanaged FOMO is how exceptions get granted, and a few exceptions are all it takes to make the label mean nothing. The remedy is transparency. Leaders should see the criteria, learn which ones they meet today, and receive the gap as a roadmap rather than a rejection.


None of that holds up unless naming has an owner. Brand and naming governance deserves the same clarity as any other decision right: who can request a change, what evidence gets submitted, who decides, how often the portfolio is reviewed, and what triggers a descriptor coming back off. With that in place, the debates still happen, they just get resolved in one cycle by the people accountable for the brand instead of drifting through six months of leadership meetings. Other industries settled this long ago. A bank does not rename a high-performing branch a financial wellness hub, and an airport does not promote itself to an aviation institute.


From Descriptors to Discipline


There is no external standard coming. No accrediting body defines what earns the institute label, which means the standard has to be internal: a written definition, a short list of criteria like the ones above, and an equally clear view of what stays a standard service line. Once those lanes exist, a naming decision becomes a five-minute check against criteria instead of a recurring debate, burning up hours of executive and physician time.


That is the real payoff. The worst outcome isn’t the wrong descriptor. It’s the quarters of executive time spent choosing it, followed by a rename two years later anyway. A written standard, applied consistently and protected on both sides, redirects that energy to the care that makes the name credible in the first place.


 
 

​Listen on

 

spotify_white.png
apple_podcast_white.png
google_podcast_white.png
  • X
  • LinkedIn
  • Instagram

Contact us

 

Copyright © 2025 Microdosing; A Podcast on the Healthcare Industry - All Rights Reserved.

 

bottom of page